Charlottes Web Holdings Inc (CWBHF)
0.1743
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Charlottes Web Holdings Enterprise Value: 21.36M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 21.36M |
| May 08, 2024 | 23.17M |
| May 07, 2024 | 25.43M |
| May 06, 2024 | 26.31M |
| May 03, 2024 | 25.96M |
| May 02, 2024 | 25.65M |
| May 01, 2024 | 24.63M |
| April 30, 2024 | 31.76M |
| April 29, 2024 | 25.29M |
| April 26, 2024 | 26.15M |
| April 25, 2024 | 26.24M |
| April 24, 2024 | 27.28M |
| April 23, 2024 | 29.24M |
| April 22, 2024 | 29.35M |
| April 19, 2024 | 29.27M |
| April 18, 2024 | 27.87M |
| April 17, 2024 | 27.45M |
| April 16, 2024 | 28.28M |
| April 15, 2024 | 28.13M |
| April 12, 2024 | 28.12M |
| April 11, 2024 | 29.96M |
| April 10, 2024 | 30.09M |
| April 09, 2024 | 30.07M |
| April 08, 2024 | 32.38M |
| April 05, 2024 | 31.83M |
| Date | Value |
|---|---|
| April 04, 2024 | 34.50M |
| April 03, 2024 | 32.22M |
| April 02, 2024 | 27.10M |
| April 01, 2024 | 27.67M |
| March 28, 2024 | 26.10M |
| March 27, 2024 | 25.55M |
| March 26, 2024 | 23.23M |
| March 25, 2024 | 20.61M |
| March 22, 2024 | 21.19M |
| March 21, 2024 | 22.18M |
| March 20, 2024 | 25.32M |
| March 19, 2024 | 22.96M |
| March 18, 2024 | 19.74M |
| March 15, 2024 | 16.61M |
| March 14, 2024 | 16.82M |
| March 13, 2024 | 17.94M |
| March 12, 2024 | 18.63M |
| March 11, 2024 | 18.54M |
| March 08, 2024 | 17.21M |
| March 07, 2024 | 17.39M |
| March 06, 2024 | 19.01M |
| March 05, 2024 | 18.48M |
| March 04, 2024 | 18.20M |
| March 01, 2024 | 18.63M |
| February 29, 2024 | 17.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.571M
Minimum
Jun 22 2023
2.187B
Maximum
Aug 05 2019
374.85M
Average
214.15M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.645M |
| Palatin Technologies Inc | 28.44M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -13.29M |
| Oragenics Inc | 4.605M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.585M |
| Revenue (Quarterly) | 15.84M |
| Total Expenses (Quarterly) | 25.64M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 55.55% |
| Profit Margin (Quarterly) | -54.18% |
| Earnings Yield | -91.80% |
| Normalized Earnings Yield | -122.31 |